Mode
Text Size
Log in / Sign up

Intraoperative dexamethasone increases maximum perioperative blood glucose by 1.86 mM in patients with diabetesTrial shows Dexamethasone impacts blood sugar during surgery for diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that intraoperative dexamethasone is associated with higher peak blood glucose but no increased infection risk.

This preplanned sub-study of an RCT included 1130 participants with diabetes mellitus and glycated haemoglobin <9.0% undergoing nonurgent, noncardiac surgery. Participants were randomized to receive either a single 8 mg dose of intraoperative dexamethasone or a placebo.

The primary outcome was the maximum recorded perioperative blood glucose concentration (mM) within 24 h of anaesthesia induction. Results showed a mean of 12.5 mM in the dexamethasone group compared to 10.3 mM in the placebo group (n=570, n=560). This represents an estimated difference of 1.86 mM (95% CI 1.50-2.22, P<0.001).

Secondary outcomes included surgical-site infection, requirement for additional insulin, and number of hypoglycaemic episodes. Surgical-site infection occurred in 11.1% of the dexamethasone group versus 14.4% of the placebo group (RR 0.74; 95% CI 0.54-1.01), which was not a significant difference.

A key limitation noted is that this was an as-treated analysis. While dexamethasone is associated with a modest increase in perioperative blood glucose, it did not significantly impact surgical-site infection rates. These findings may support the use of dexamethasone for managing postoperative nausea and vomiting despite the observed glucose elevation.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap regarding the metabolic effects of dexamethasone in patients with diabetes during surgery. While previous coverage noted that dexamethasone was used to achieve remission in a patient with AL amyloidosis and POEMS syndrome, and as an alternative for COVID-19 treatment, this study specifically quantifies the impact on perioperative blood glucose levels in a diabetic population.

Researchers studied 1,130 people with diabetes who were undergoing nonurgent, noncardiac surgery. The goal was to see how a single 8 mg dose of the steroid dexamethasone affected their blood sugar levels compared to a placebo during the first 24 hours after anesthesia.

The results showed that patients who received dexamethasone had higher peak blood glucose levels than those who received the placebo. Specifically, the dexamethasone group reached levels of 12.5 mM while the placebo group reached 10.3 mM. However, there was no significant difference in the rates of surgical-site infections between the two groups.

Because this was a preplanned sub-study of a larger trial, it is important to note that these results are linked specifically to this patient group. While dexamethasone can cause an increase in blood sugar, it is often used to prevent nausea and vomiting after surgery. Patients should talk to their doctors about how these findings might affect their specific treatment plan.

What this means for you:
Dexamethasone was associated with higher blood glucose levels during surgery but did not change infection rates.

Common questions

Does dexamethasone affect blood sugar in diabetic patients?

The study showed that a single 8 mg dose of dexamethasone was associated with higher peak blood glucose levels within 24 hours of anesthesia. Patients who received the medication had an average level of 12.5 mM, while those who received a placebo had a lower average of 10.3 mM.

Does dexamethasone increase the risk of infection after surgery?

The study found no significant difference in surgical-site infections between patients who received dexamethasone and those who received a placebo. The infection rate was 11.1% for the dexamethasone group and 14.4% for the placebo group, which did not show a statistically significant difference.

Why is dexamethasone used if it can raise blood sugar?

While dexamethasone was associated with a modest increase in blood glucose during surgery, it is commonly used to help prevent nausea and vomiting after a procedure. Patients should discuss the balance of these effects with their medical team.

Study Details

Study typeRct
Sample sizen = 570
EvidenceLevel 2
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: The Perioperative ADministration of Dexamethasone and Infection (PADDI) randomised placebo-controlled trial showed that a single 8 mg dose of intraoperative dexamethasone had no effect on surgical-site infection within 30 days after nonurgent, noncardiac surgery. Whether dexamethasone increases blood glucose and adverse outcomes in people with diabetes mellitus remains unclear. METHODS: In this preplanned sub-study, 1130 PADDI participants (mean age 65.2 y: 40.7% female) with diabetes mellitus and glycated haemoglobin <9.0% were included in this 'as treated' analysis. The primary outcome was the maximum recorded perioperative blood glucose concentration (mM) within 24 h of anaesthesia induction. RESULTS: The maximum perioperative blood glucose level was 12.5 mM (median, IQR 10.6-15.0) in 570 participants receiving dexamethasone, compared with 10.3 mM (8.8-12.4) in 560 participants receiving placebo (estimated difference 1.86 mM (95% CI 1.50-2.22), P<0.001). There was no evidence of increased risk of surgical-site infection (dexamethasone 11.1% vs placebo 14.4%, risk ratio [RR], 0.74; 95% confidence interval [CI], 0.54-1.01). Age, sex, BMI and HbA1c were not associated with maximum perioperative glucose levels or the incidence of surgical-site infections between the dexamethasone and placebo groups. The requirement for additional insulin and the number of hypoglycaemic episodes did not differ between groups. CONCLUSION: In people with diabetes mellitus, dexamethasone was associated with a modest increase in perioperative blood glucose but not with increased surgical-site infection. These findings support the use of dexamethasone to prevent postoperative nausea and vomiting in people with diabetes mellitus.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.